Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer

Background: Randomized trials have established that 5-fluorouracil-based adjuvant chemotherapy following resection of stage III colon cancer reduces subsequent mortality by as much as 30%. However, the extent to which adjuvant therapy is used outside the clinical trial setting, particularly among th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2001-06, Vol.93 (11), p.850-857
Hauptverfasser:	Schrag, Deborah, Cramer, Laura D., Bach, Peter B., Begg, Colin B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Distribution Age Factors Aged Aged, 80 and over Antineoplastic agents Biological and medical sciences Centers for Medicare and Medicaid Services (U.S.) Chemotherapy Chemotherapy, Adjuvant - statistics & numerical data Cohort Studies Colonic Neoplasms - drug therapy Colonic Neoplasms - mortality Colonic Neoplasms - pathology Colonic Neoplasms - surgery Comorbidity Continental Population Groups Databases, Factual Female Humans Income Lymphatic Metastasis Male Medical sciences Medicare Neoplasm Staging Pharmacology. Drug treatments Registries Retrospective Studies Survival Rate Time Factors United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!